GlassScriptPhysician profile
Krishn M Sharma
NPI 1235190240
$296,160.83
in general payments reported to CMS, 2019-2025
35 companies · $851 in 2025
The $851 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137K · 2020: $89K · 2021: $42K · 2022: $19K · 2023: $3,512 · 2024: $4,294 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,037 · Travel and Lodging: $2,651 · Consulting Fee: $970.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,036.57 |
| Travel and Lodging | $2,650.55 |
| Consulting Fee | $970.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Precision Spine, INC. | $265,221.49 | 2019-2022 | |
| Wound Management Technologies, INC | $9,707.78 | 2019 | |
| Sanara Medtech INC. | $7,127.17 | 2020-2023 | Celleraterx |
| Stryker Corporation | $5,415.01 | 2019-2024 | Everest Spinal System, Spinemap, Yukon Oct Spinal System |
| Si-Bone, INC. | $2,693.15 | 2019-2024 | |
| Imbed Biosciences INC. | $1,494.02 | 2023 | |
| Medtronic, INC. | $554.60 | 2021-2025 | Kyphon Express II Kyphopak Tray, O-Arm, Medtronic Reusable Instruments |
| Djo, LLC | $455.15 | 2023-2025 | Cmf |
| Medtronic USA, INC. | $368.46 | 2019-2020 | |
| Orthofix Medical, INC. | $303.53 | 2019-2024 | Shoreline Asc |
| Globus Medical, INC. | $266.80 | 2019-2025 | Modulus |
| Nevro Corp. | $266.12 | 2020-2024 | Senza |
| Arteriocyte Medical Systems, INC. | $240.47 | 2024 | Magellan |
| Vb Spine LLC | $235.88 | 2025 | Chesapeake Stabilization System |
| Seaspine Orthopedics Corporation | $223.37 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $222.97 | 2019-2025 | Symphony, Monovisc |
| Nuvasive, INC. | $193.38 | 2021 | |
| Providence Medical Technology, INC. | $177.25 | 2024 | |
| Axogen | $166.28 | 2021 | |
| Spinal Elements, INC. | $149.76 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $112.27 | 2023-2024 | Farxiga |
| Gs Solutions, INC. | $108.08 | 2023 | |
| Surgalign Spine Technologies, INC. | $97.38 | 2019-2021 | |
| Elevation Spine, INC. | $80.42 | 2023 | |
| Royal Biologics, INC. | $62.02 | 2025 | |
| Spineology INC. | $52.89 | 2019 | |
| Alphatec Spine, INC | $38.59 | 2025 | Other - Miscellaneous |
| Abbvie INC. | $33.96 | 2024 | |
| Ibsa Pharma INC. | $19.32 | 2023 | Tirosint, Licart |
| Medical Device Business Services, INC. | $17.93 | 2019 | |
| Spinal Simplicity, LLC | $17.44 | 2019 | |
| Endo USA, INC. | $17.22 | 2025 | Xiaflex |
| The Institute of Musculoskeletal Science and Education | $10.94 | 2019 | |
| 7d Surgical INC. | $9.73 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,050.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishn Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.